AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04090502 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Dry needling in hamstring muscle not trigger points
Description: Participants with nonspecific mechanical low back pain will be assessed for the hamstring muscle. Subsequently, the most sensitive areas associated with the shortening of the muscle will be located and the technique will be applied out of this area.
Study NCT03744052 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motivational Messages
Description: Messages regarding physical activity will be texted to participants.
Study NCT03437655 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Carie removal
Description: Carie removal with a low speed handpiece
Study NCT01071629 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise training
Description: Interval training (30 sec 50% of peak Work Rate achieved at the steep ramp test/60 sec recovery no exercise) for 40 min in the interval training group
Study NCT02350660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: cow's milk
Description: daily consumption of cow's milk
Study NCT02350660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: peanut powder
Description: peanut oral immunotherapy
Study NCT03437655 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Relative isolation
Description: Relative isolation with cotton and gauze.
Study NCT03437655 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manipulation of the temporary material based on Zinc Oxide and Eugenol
Description: Manipulation of the temporary material based on Zinc Oxide and Eugenol according to the manufacturer's recommendations
Study NCT03437655 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manipulation of the temporary material based on Mineral trioxide aggregate
Description: Manipulation of the temporary material based on Mineral trioxide aggregate according to the manufacturer's recommendations
Study NCT03437655 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Material insertion on the cavity
Description: Material insertion on the cavity according to the manufacturer's recommendations
Study NCT03437655 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Finishing the temporary direct restoration
Description: Excess cement removal; Occlusal Adjustment; Finishing and polishing.
Study NCT01071629 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise training
Description: Interval training (30 sec 50% of peak Work Rate achieved at the steep ramp test/60 sec recovery no exercise) for 20 min and Strength training of the quadriceps, hamstrings, muscles of the shoulder and biceps brachialis for 20 min 3 times per week for 36 sessions
Study NCT02338375 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cartistem
Description: Cartistem is allogenic umbilical cord blood-derived stem cell product. Cartistem is 500uL/cm2 applied according to the lesion.
Study NCT02338375 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Cartistem
Description: Cartistem is allogenic umbilical cord blood-derived stem cell product. Cartistem is 500uL/cm2 applied according to the lesion.
Study NCT05545644 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Family-Involved Treatment for Alcohol Use Disorder
Description: Up to 3 sessions of counseling involving a patient with alcohol use disorder and a concerned family member
Study NCT05545644 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brief Family-Involved Treatment for Alcohol Use Disorder
Description: Up to 3 sessions of counseling involving a patient with alcohol use disorder and a concerned family member
Study NCT00909909 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: External beam boost
Description: 3-dimensional conformal radiation therapy and intensity modulated radiation therapy
Study NCT00909909 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: whole breast irradiation
Description: accelerated, hypofractionated whole breast irradiation
Study NCT03985397 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: discharge training
Description: Providing planned discharge training according to the level of knowledge about diet, drug and individual monitoring compliance and cardiovascular risk factors of patients with acute myocardial infarction
Study NCT05659342 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ELDOA Technique
Description: the patients treated with ELDOA technique, followed for 3 alternative days for 4 weeks.~the ELDOA techniques for level L4/L5 and L5/S1 were applied. the ELDOA positions hold for one minute, 3 alternative days for 4 weeks under supervision.~Hot pack (10-15 minutes) McKenzie Extension Exercises
Study NCT05659342 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mechanical Lumbar Traction
Description: Mechanical Traction Technique: traction unit, 50% of body weight was applied with the patients lying in supine position, with the hip and knee at 90 degree flexion, and legs were supported. Traction were applied for 3 alternative days for 4 weeks.~Hot pack (10-15 minutes) McKenzie Extension Exercises
Study NCT00786188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brisdelle (paroxetine mesylate)
Description: Eligible subjects will be randomized to receive Brisdelle™ (paroxetine mesylate) Capsules 7.5 mg.
Study NCT00786188 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sugar pill
Description: Subjects will receive a sugar pill.
Study NCT03791190 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation
Description: Sodium citrate (4%) infusion before the filter in order to maintain post-filter ionCa2+ level between 0.25 to 0.35 mmol/L. Calcium gluconate supplementary after the filter to maintain serum ionCa2+ level between 1.0 to 1.2 mmol/L.
Study NCT03791190 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No-anticoagulation
Description: Patients accepted CRRT without anticoagulant.
Study NCT02142881 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Antihypertensive medication intensification
Description: Antihypertensive medications will be adjusted by study staff based on ambulatory and clinic BP results at baseline and 2 months with a target 24hr systolic blood pressure of \<130 mmHg.
Study NCT02142881 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: Antihypertensive medications will be adjusted by the participants' providers (usual care).
Study NCT01643109 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Casting & CIMT
Description: A standardized CIMT protocol will be administered over a three week period. The first week will consist of wearing a below elbow cast on the non-hemiplegic limb followed by a two week CIMT camp (5 hours per day, 5 days per week) where the child/youth wears a constraint splint on the non-hemiplegic hand. The two week camp will follow a standardized CIMT camp protocol (Hand2Hand developed at HBKRH) that includes activities that focus on unilateral hemiplegic hand activity in the first week and increasing incorporation of bilateral hand activities in the second week. The camp protocol for CIMT is based on camp protocols utilized successfully in other paediatric research studies.
Study NCT02612558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fostamatinib 150 mg bid
Description: Fostamatinib 150 mg bid. The dose of Fostamatinib may be reduced at any time to as low as 100 mg PO once daily (qd) if dose limiting adverse events are observed.
Study NCT01960972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Salt substitute
Description: A salt substitute using 25% of potassium chloride and 75% of sodium chloride will be implemented in each of the villages.
Study NCT04214457 — intervention group
Intervention type: PROCEDURE
Intervention: Biopsy and peripheral blood collection
Description: After obtaining informed consent, the samples (tumor tissue and peripheral blood) will be collected at the time of surgery, which the patient had already planned by medical indication according to the usual clinical practice. Part of the sample will be sent to histopathology for gold standard diagnosis while the rest of the sample will be sent to Igenomix for molecular analysis.~If samples are available from patients who underwent surgery prior to the study, after they sign the Informed Consent, the samples will be sent to Igenomix for molecular analysis and the results obtained by histopathology will be collected from the patient's medical record.
Study NCT02444195 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided Imagery With Audio Media
Description: Subjects assigned to the experimental arm will be asked to participate in meditation daily using the audio media provided for the 7 days prior to surgery, in the preoperative holding area, for the 7 days following surgery, and are encouraged to engage in affirmations module use at least weekly in the 6-8 week postoperative period.
Study NCT02924051 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: Baseline and monthly assessment of barriers/facilitators of dietary change, ambivalence to change and coaching to resolve barriers and ambivalence.
Study NCT02924051 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cooking skills and nutritional education
Description: Participants in this group will develop an understanding of healthy food options and healthy food preparation.
Study NCT05441293 — intervention group
Intervention type: PROCEDURE
Intervention: flap reconstruction
Description: received flap reconstruction over sacrum, back, trochanter, ischium, elbow, and lower extremities
Study NCT03234010 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FT21092
Description: An electronic cigarette
Study NCT04957030 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ULDCT group
Description: underwent ultralow-dose chest CT
Study NCT03122977 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FM-SRP
Description: Supra- and sub-gingival mechanical instrumentation of the root surface of the whole dentition within 24 hours.
Study NCT03122977 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Q-SRP
Description: Supra- and sub-gingival mechanical instrumentation of the root surface will be performed in all dentition subdivided in four appointments. Each appointment will be performed in one week interval. In each appointment only a quadrant of the dentition will be instrumented.
Study NCT01015469 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional laparoscopic Roux-en-Y gastric bypass
Description: Conventional laparoscopic Roux-en-Y gastric bypass
Study NCT01015469 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring
Description: conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring (GaBP-Ring)
Study NCT02934191 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Description: Dosing will be 6mg/kg twice a day with a maximum dose of 300mg twice a day. All ages will be given the suspension (concentration 100mg/5mL) orally
Study NCT02934191 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo will have the same appearance, taste and consistency as celecoxib. Placebo will consist of calcium carbonate powder suspended in the same syrup as celecoxib. Dose of elemental calcium is 3 mg/kg/day.
Study NCT02934191 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Acetaminophen syrup at a dose of 15mg/kg/dose will be given every 4 hours for the first 5 days after surgery. After that point, is given as needed.
Study NCT02934191 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: Acetaminophen syrup at a dose of 15mg/kg/dose will be given every 4 hours for the first 5 days after surgery. After that point, is given as needed.
Study NCT02934191 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone
Description: Oxycodone may be used every 4 hours post-operatively to treat breakthrough pain. The most commonly prescribed dose is 0.075mg/kg/dose (suspension) every 4 hours as needed.
Study NCT02934191 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone
Description: Oxycodone may be used every 4 hours post-operatively to treat breakthrough pain. The most commonly prescribed dose is 0.075mg/kg/dose (suspension) every 4 hours as needed.
Study NCT06550713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3455 tablet+Azacitidine for Injection
Description: TQB3455 is a selective IDH2 mutant enzyme inhibitor. Azacitidine for injection is a cytosine nucleoside drug that is used for demethylation therapy.
Study NCT04505254 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acalabrutinib
Description: Given PO
Study NCT04505254 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: Given IV
Study NCT03431545 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PALS and
Description: Play and Learning Strategies (PALS) include web-based parent training courses with remote coaching and in-person meetings that support the adults' developing a set of core behaviors that comprise a responsive interactive style including responses contingent to children's needs and interests with rich language input.~Parents will begin their 11 week (infant) or 14 week (toddler) parenting program in October and complete it by April. There will be monthly Parent Meetings related to the content they are learning online. Post-assessments will occur in late April and May. Each weekly online parent session will take approximately 30 minutes to complete with a 40 - 60 minute weekly remote coach call.
Study NCT03431545 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BEECH
Description: Beginning Education: Early Childcare at Home (BEECH) includes web-based teacher training courses with remote coaching and in-person meetings that support the adults' developing a set of core behaviors that comprise a responsive interactive style including responses contingent to children's needs and interests with rich language input.~Teachers will complete the 20 online sessions weekly, except for planned center closings due to holidays or agency-related events. The three in-person trainings will occur before Session 1 and after Sessions 8 and 14. Each weekly online teacher session will take approximately one-hour for a teacher to complete with a 30 minute weekly remote coach call. Each in-person teacher training will be 6-hours in duration.
Study NCT03431545 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control condition
Description: Parents and teachers conduct business as usual in regards to care-giving in the school and at home.
Study NCT02952586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Avelumab + SOC Chemoradiation
Study NCT02952586 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Chemoradiation
Description: Cisplatin + Radiation Therapy
Study NCT01425658 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: distilled water
Description: The placebo group (group P) received bupivacaine 10mg combined with 0.5ml distilled water intrathecally .
Study NCT01425658 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clonidine
Description: The clonidine group (group C) received bupivacaine 10mg combined with 75 microgram clonidine intrathecally .
Study NCT01425658 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: The Fentanyl group (group F) received bupivacaine 10mg combined with 25 microgram fentanyl intrathecally .
Study NCT02986477 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Contrast Ultrasound
Description: For diagnostic purposes, intravesicle administration of contrast ultrasound agent will be performed to study vesicoureteral reflux.
Study NCT03234010 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FT21093
Description: An electronic cigarette
Study NCT03234010 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FT21096
Description: An electronic cigarette
Study NCT02470845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: herbal patches of Tian Jiu group
Description: The formula of herbal patch consists of BaiJieZi (Sinapis Semen), Yan Hu Suo（CorydulisRhizoma）、ZhiGan Sui (Kansui Radix)、Xi Xin (Asari Radix et rhizama) and Rengong She xiang(Moschus Artifactus) . The four herbs will be ground into powder, mixed thoroughlywith 20% BaiJieZi (Sinapis Semen), 25% Yan Hu Suo（CorydulisRhizoma), 15% ZhiGan Sui (Kansui Radix), and 40% Xi Xin (Asari Radix et rhizama), and the mixed powder will mix with fresh ginger juice in the ratio of 20g to 25 ml. The mixture will be made to a patch weighted as 2g and 1cm\*1cm round size. 0.02g artificial She Xiang (Moschus Artifactus) will be added on top of each patch. Each patch will be applied on one acupoint.
Study NCT02470845 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: placebo patches of placebo-control group
Description: The placebo patch consists of flour and edible pigments. These two ingredients will be mixed with water and made to patches weighted as 2g and 1cm\*1cm round size.Each patch will be applied on one acupoint.
Study NCT02786225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collaborative Care
Description: Intervention Group: Women (n=118) will be seen one time, simultaneously by a VUMC perinatologist and a VUSN nurse-midwife (the CARE visit). During the CARE visit, the nurse-midwife and perinatologist will complete the CARE checklist The checklist will be signed by the woman and providers and scanned into the medical record. Following the CARE visit, women will return to midwifery care or be referred to perinatology depending on their needs, remaining in the study. Women returning to the midwifery practice will see a primary midwife for the remainder of care.
Study NCT02786225 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Comparison Care- Usual Care + primary midwife
Description: Comparison Group: Usual care enhanced with primary midwife. Women in the comparison group (n=118) will receive the standard individual consult visit with a perinatologist and then, if they return to midwifery care, have one consistent midwife (primary midwife) for the majority of remaining prenatal care.
Study NCT01577550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 655066 (very high i.v. dose)
Description: Single very high i.v. dose BI 655066
Study NCT02861911 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Current flow between sensory and motor threshold
Description: Artificial strength training by means of neuromuscular electrical stimulation (NMES)
Study NCT02861911 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Current intensity upper of motor threshold by Kneehab XP technology
Description: Artificial strength training by means of neuromuscular electrical stimulation (NMES)
Study NCT03121170 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: extracorporeal shock wave therapy
Description: Intervention group is by extracorporeal shock wave therapy.A radial shock wave device (EMS Swiss Dolor, Munich, Germany) was used. Radial shock wave is created ballistically with the pressurized air source accelerating a bullet to strike a metal applicator. The kinetic energy produced is transformed into radially expanding shock waves from the application site into the tissue to be treated. The treatment of area is lower abdomen which has some acupuncture points such as Shenque(CV8) ,Qihai(BL24), Guanyuan(CV4), Zhongji(CV3), Tianshu(ST25), Guilai(ST29) and Zigong(EX-CA1) at the right and left sides of the lower abdomen. All acupuncture points should be placed according to participants' feedback during treatment.
Study NCT03121170 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: hot compress paste
Description: Hot compress pastes will be sticked on the lower abdomen.
Study NCT00990522 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: debridement
Description: There will be two (2) subject groups in the study. Subjects will be randomized into either the monthly debridement group or the weekly debridement group.
Study NCT01335360 — intervention group
Intervention type: DRUG
Intervention: Nevirapine
Description: 200mg twice daily of nevirapine
Study NCT03362827 — intervention group
Intervention type: OTHER
Intervention: Chronic low back pain patients
Description: People must have experienced low back pain for at least 3 months and have reported a minimal pain level of 30 (pain threshold) on the 0-100 pain numerical rating scale (NRS) in the last 7 days.
Study NCT03362827 — intervention group
Intervention type: OTHER
Intervention: Subjects without chronic low back pain
Description: These participants must not have presented episodes of low back pain for more than 7 days in the last 12 months.
Study NCT01997333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CDX-011
Study NCT01997333 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Study NCT00743626 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Diagnostic cervical cancer screening tests (Pap smear, HPV and/or p16)
Description: If positive (Pap smear, HPV and/or p16) patients will be scheduled for 3 colposcopy follow up visits (1,12,18 months)